Rapid-acting treatment for a common sleep problem

D Bramble1

  • 1Department of Child and Adolescent Psychiatry, Queen's Medical Centre, Nottingham, UK.

Insights

A behavioral intervention package significantly improved sleep patterns in children with severe learning disabilities and chronic sleep disorders. These positive sleep outcomes were sustained long-term, with additional benefits observed in daytime behavior.

Area of Science:

  • Pediatrics
  • Developmental Psychology
  • Sleep Medicine

Background:

  • Chronic sleep disorders are common in children with severe learning disabilities.
  • These sleep issues can be handicapping and impact overall well-being.
  • Existing interventions may have limited effectiveness or long-term data.

Purpose of the Study:

  • To evaluate the effectiveness of a behavioral modification package for chronic sleep disorders in children with severe learning disabilities.
  • To assess the short-term and long-term sustainability of the intervention's effects.
  • To explore potential secondary benefits of the intervention.

Main Methods:

  • A behavioral modification package including stimulus control, cueing, and rapid-extinction techniques was implemented.
  • The intervention was applied to a group of 15 children with severe learning disabilities and chronic sleep disorders.
  • Outcomes were assessed through night-settling and night-waking patterns, with follow-up at 18 months.

Main Results:

  • Rapid improvements in night-settling and night-waking patterns were observed within days for most children.
  • Positive sleep outcomes were sustained in 12 out of 15 children at 18-month follow-up.
  • Secondary benefits, including improved daytime behavior and reduced maternal stress, were noted.

Conclusions:

  • Behavioral interventions are effective for treating chronic sleep disorders in children with severe learning disabilities.
  • The applied package demonstrates sustained efficacy and potential for wider application.
  • Addressing sleep disorders in this population can lead to significant improvements in quality of life.

Related Concept Videos

Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.